Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly
NCT ID: NCT03878043
Last Updated: 2019-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
167 participants
OBSERVATIONAL
2014-01-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparative Analysis of Prognostic Factors for Functional Outcomes in Patients With Acute Subdural Hematoma
NCT06364059
Delayed Cerebral Ischaemia and Coagulation Alterations After Aneurysmal Subarachnoid Haemorrhage
NCT03985176
Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation
NCT04272996
Age, Traumatic Brain Injury and Injury Severity as Independent Risk Factors for In-Hospital Mortality in Polytrauma Patients.
NCT04335838
Evaluation of Surgery in Elderly With Traumatic Acute SubDural Hematoma
NCT04648436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients without Readmissions
Patients with TSDH who were not readmitted within a 6-month time period following their initial visit.
No interventions assigned to this group
Patients with Readmissions
Patients with TSDH who were readmitted within a 6-month time period following their initial visit.
Follow-up Care
Follow up care provided upon readmission to patients who were diagnosed with a TSDH upon initial visit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up Care
Follow up care provided upon readmission to patients who were diagnosed with a TSDH upon initial visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
105 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tarik Wasfie, MD
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tarik Wasfie, MD
Professor, Department of Trauma Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tarik Wasfie, MD
Role: PRINCIPAL_INVESTIGATOR
Ascension Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Genesys Regional Medical Center
Grand Blanc, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRMC 160013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.